United States · FDA National Drug Code directory
CLOZAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-846_a46da176-2ed3-4b9a-b06f-efab2936a5ee
- Product NDC
- 65862-846
- Form
- TABLET
- Composition / generic term
- CLOZAPINE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161129
- Source listing expiry
- 20261231
Source-listed ingredients
- CLOZAPINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-846-01) · 65862-846-01
- 500 TABLET in 1 BOTTLE (65862-846-05) · 65862-846-05
- 10 BLISTER PACK in 1 CARTON (65862-846-78) / 10 TABLET in 1 BLISTER PACK (65862-846-10) · 65862-846-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →